Charles Schwab’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.26M | Buy |
|
|||||
|
2025
Q1 | $6.17M | Buy |
|
|||||
|
2024
Q4 | $8.84M | Buy |
|
|||||
|
2024
Q3 | $9.8M | Buy |
|
|||||
|
2024
Q2 | $2.31M | Buy |
|
|||||
|
2024
Q1 | $569K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $246K | Buy |
|
|||||
|
2021
Q4 | $473K | Hold |
|
|||||
|
2021
Q3 | $791K | Sell |
|
|||||
|
2021
Q2 | $737K | Sell |
|
|||||
|
2021
Q1 | $878K | Sell |
|
|||||
|
2020
Q4 | $885K | Buy |
|
|||||
|
2020
Q3 | $750K | Sell |
|
|||||
|
2020
Q2 | $1.01M | Buy |
|
|||||
|
2020
Q1 | $283K | Buy |
|
|||||
|
2019
Q4 | $456K | Hold |
|
|||||
|
2019
Q3 | $459K | Hold |
|
|||||
|
2019
Q2 | $409K | Buy |
|
|||||
|
2019
Q1 | $359K | Buy |
|
|||||
|
2018
Q4 | $309K | Buy |
|
|||||
|
2018
Q3 | $290K | Hold |
|
|||||
|
2018
Q2 | $321K | Buy |
|